NewEdge Advisors’s Lantern Pharma LTRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $179K | Sell |
56,507
-3,417
| -6% | -$10.8K | ﹤0.01% | 2253 |
|
|
2025
Q1 | $212K | Sell |
59,924
-8,435
| -12% | -$29.9K | ﹤0.01% | 2067 |
|
|
2024
Q4 | $218K | Sell |
68,359
-68,979
| -50% | -$220K | ﹤0.01% | 2050 |
|
|
2024
Q3 | $504K | Sell |
137,338
-19,786
| -13% | -$72.6K | ﹤0.01% | 1480 |
|
|
2024
Q2 | $734K | Sell |
157,124
-3,408
| -2% | -$15.9K | 0.01% | 1209 |
|
|
2024
Q1 | $1.41M | Sell |
160,532
-5,440
| -3% | -$47.9K | 0.01% | 831 |
|
|
2023
Q4 | $710K | Sell |
165,972
-4,059
| -2% | -$17.4K | 0.01% | 1109 |
|
|
2023
Q3 | $580K | Sell |
170,031
-1,434
| -0.8% | -$4.89K | 0.01% | 1106 |
|
|
2023
Q2 | $967K | Sell |
171,465
-650
| -0.4% | -$3.67K | 0.01% | 886 |
|
|
2023
Q1 | $831K | Sell |
172,115
-723
| -0.4% | -$3.49K | 0.01% | 866 |
|
|
2022
Q4 | $1.04K | Buy |
172,838
+1,819
| +1% | +$11 | ﹤0.01% | 3025 |
|
|
2022
Q3 | $817K | Buy |
171,019
+1,047
| +0.6% | +$5K | 0.01% | 732 |
|
|
2022
Q2 | $971K | Buy |
169,972
+201
| +0.1% | +$1.15K | 0.02% | 676 |
|
|
2022
Q1 | $1.21M | Buy |
169,771
+2,665
| +2% | +$19.1K | 0.02% | 575 |
|
|
2021
Q4 | $1.33M | Buy |
167,106
+11,247
| +7% | +$89.8K | 0.02% | 605 |
|
|
2021
Q3 | $1.74M | Buy |
155,859
+4,543
| +3% | +$50.8K | 0.04% | 354 |
|
|
2021
Q2 | $2.21M | Buy |
+151,316
| New | +$2.21M | 0.06% | 282 |
|